THE PHARMACOKINETIC INTERACTION BETWEEN METHADONE AND THE INVESTIGATIONAL HCV PROTEASE INHIBITOR TELAPREVIR

被引：0
|
作者：
van Heeswijk, Rolf [1 ]
Vandevoorde, Ann [1 ]
Verboven, Peter [2 ]
Boogaerts, Griet [1 ]
De Paepe, Els [1 ]
van Solingen-Ristea, Rodica [1 ]
Beumont, Maria [1 ]
机构：
[1] Tibotec BVBA, Beerse, Belgium
[2] Janssen Res & Dev, Beerse, Belgium
来源：
SWISS MEDICAL WEEKLY | 2011年 / 141卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
H8
引用
收藏
页码：18S / 18S
页数：1
相关论文
共 50 条
  • [1] THE PHARMACOKINETIC INTERACTION BETWEEN METHADONE AND THE INVESTIGATIONAL HCV PROTEASE INHIBITOR TELAPREVIR
    van Heeswijk, R.
    Vandevoorde, A.
    Verboven, P.
    Boogaerts, G.
    De Paepe, E.
    van Solingen-Ristea, R.
    Garg, V.
    Beumont, M.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S491 - S492
  • [2] THE PHARMACOKINETIC INTERACTION BETWEEN THE INVESTIGATIONAL NS3-4A HCV PROTEASE INHIBITOR TMC435 AND METHADONE
    Beumont-Mauviel, Maria
    De Smedt, Goedele
    Peeters, Monika
    Akuma, Sophie H.
    Sekar, Vanitha
    HEPATOLOGY, 2011, 54 : 1000A - 1000A
  • [3] Pharmacokinetic Interaction between Telaprevir and Methadone
    van Heeswijk, Rolf
    Verboven, Peter
    Vandevoorde, Ann
    Vinck, Petra
    Snoeys, Jan
    Boogaerts, Griet
    De Paepe, Els
    Van Solingen-Ristea, Rodica
    Witek, James
    Garg, Varun
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (05) : 2304 - 2309
  • [4] The Pharmacokinetic Interaction Between an Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone and the HCV Protease Inhibitor Telaprevir
    Garg, Varun
    van Heeswijk, Rolf
    Yang, Yijun
    Kauffman, Robert
    Smith, Frances
    Adda, Nathalie
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (10): : 1574 - 1583
  • [5] Pharmacokinetic interaction between HCV protease inhibitor boceprevir and methadone or buprenorphine in subjects on stable maintenance therapy
    Ellen G. J. Hulskotte
    R. Douglas Bruce
    Hwa-Ping Feng
    Lynn R. Webster
    Feng Xuan
    Wen H. Lin
    Edward O’Mara
    John A. Wagner
    Joan R. Butterton
    European Journal of Clinical Pharmacology, 2015, 71 : 303 - 311
  • [6] Pharmacokinetic interaction between HCV protease inhibitor boceprevir and methadone or buprenorphine in subjects on stable maintenance therapy
    Hulskotte, Ellen G. J.
    Bruce, R. Douglas
    Feng, Hwa-Ping
    Webster, Lynn R.
    Xuan, Feng
    Lin, Wen H.
    O'Mara, Edward
    Wagner, John A.
    Butterton, Joan R.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (03) : 303 - 311
  • [7] Pharmacokinetic interaction between HCV protease inhibitor boceprevir and methadone or buprenorphine in subjects on stable maintenance therapy
    Hulskotte, Ellen G.
    Feng, Hwa Ping
    Bruce, Robert D.
    Webster, Lynn R.
    Xuan, Fengjuan
    Lin, Wen Hong
    O'Mara, Edward
    Wagner, John A.
    Butterton, Joan R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 169 - 170
  • [8] Significant Effect of the Investigational HCV Protease Inhibitor Telaprevir on Cyclosporine and Tacrolimus Pharmacokinetics
    Garg, V.
    Luo, X.
    Alves, K.
    Alexander, L.
    Lee, J. E.
    Lewis, W.
    van Heeswijk, R.
    Kauffman, R. S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 48 - 48
  • [9] THE EFFECT OF SEVERE RENAL IMPAIRMENT ON THE PHARMACOKINETICS OF THE INVESTIGATIONAL HCV PROTEASE INHIBITOR TELAPREVIR
    van Heeswijk, R.
    Vandevoorde, A.
    Boogaerts, G.
    De Paepe, E.
    van Solingen-Ristea, R.
    Garg, V.
    Beumont, M.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S492 - S492
  • [10] No pharmacokinetic interaction between the investigational HCV protease inhibitor TMC435 and an oral contraceptive containing ethinylestradiol and norethindrone
    Ouwerkerk-Mahadevan, Sivi
    Beumont, Maria
    Spittaels, Kurt F.
    Simion, Alexandru
    Peeters, Monika
    HEPATOLOGY, 2012, 56 : 565A - 566A
12345